Search Results

conduct the CTLS shared decision-making visit. 7 All CTLS examinations were performed on ≥64-row multidetector CT scanners at 100 kV and 30 to 100 mA depending on availability of iterative reconstruction software. Image interpretation was performed by

provider Promote policies and reimbursement mechanisms that support interoperability and encourage the aggregation of patient data that will promote shared decision-making and increase understanding between patients, providers, and payers Maintain and

has worked elsewhere, and making sure these discussions include input from patient advocates. Visit NCCN.org to learn more about the tools NCCN provides to encourage prevention and enable shared decision-making between patients and providers

, monitoring, and management for patients and survivors. 17 The use of PROs in everyday clinical practice can promote better communication and shared decision-making by patients and providers, and help distinguish physical, emotional, and social issues that

aggressive treatment for fit patients and more conservative therapies for frail patients. Taking the differing outcomes of these groups into account, the patient and oncologist can develop a treatment plan in a shared decision-making process that incorporates

cancer information and screening programs. 20 Although the benefit of prostate cancer screening is still under debate, 21 , 22 the American Cancer Society and the American Urological Association recommend shared decision-making between patients and

MM , Faghri A , Jacobs EA , Communication and shared decision making in the breast cancer treatment consultation: a comparative analysis of English- and Spanish-speaking patients . MDM Policy Pract 2019 ; 4 : 2381468319881651 . 31696154

intermediate-risk prostate cancer to better inform shared decision-making between patients and healthcare providers. Improved patient selection and surveillance protocols may be needed to reduce the risks of AS for men with favorable intermediate-risk prostate

the highest risk of VTE. We are hopeful that this clinical tool will aid informed shared decision-making between providers and patients with MM regarding VTE risk before IMiD initiation. Future prospective studies are needed to define the best VTE

critical in guiding decisions regarding care, monitoring strategies, aggressiveness of therapy, and patient counseling to enable shared decision-making. 10 Yet, although overall survival, recurrence-free survival, and associated prognostic factors have